Immunotherapy research makes cancer treatment easier on kids

Stephen Mathew, PhD

Today more than 75 percent of children with leukemia are cured, but survival often comes at a cost. The very drugs that save lives can cause severe side effects later.

To reduce those risks, researchers at UNT Health Science Center are studying ways to use a patient’s own immune system to destroy cancer cells. Once viewed with skepticism, this approach is showing great promise in the treatment of multiple myeloma, melanoma and other cancers.

The Cancer Research Institute has named June Cancer Immunotherapy Month. Supporters are urged to wear white on Friday as part of White Out Cancer Day.

The benefits of immunotherapy are especially important for children with acute lymphoblastic leukemia (ALL), which typically strikes between the ages of 2 and 5. Although ALL has a high survival rate, the drugs used to treat it are very harsh, said Stephen Mathew, PhD, Assistant Professor of Cell Biology & Immunology.

"Just imagine giving a 2-year-old baby all of these toxic chemicals," Dr. Mathew said. "Yes, the cure rate is high, but at what cost?"

With immunotherapy, the child’s immune system is revved up to attack cancer cells, while sparing healthy ones. While the approach might sound simple, the immune system is very complex, Dr. Mathew said.

He is collaborating with Paul Bowman, MD, Chairman of Pediatrics, and Porunelloor Mathew, PhD, Vice Chairman Cell Biology & Immunology, for a study on ALL.

So far much of the immunotherapy research has focused on T cells, which kill infected cells and regulate the immune system, and B cells, which are involved in the production of antibodies, Dr. Mathew said.

But UNTHSC researchers are taking a different approach.

"Our lab is working on NK cells, which are the first line of defense against cancer, bacterial and virally infected cells," Dr. Mathew said. "An antibody developed against one of the NK cell receptors, discovered in our lab, is currently in clinical trials for multiple myeloma."

The hope is to translate basic science findings into therapeutic interventions for patients.

"With immunotherapy, we are not using harsh chemicals. We’re making it possible for the body to boost its own immune system," Dr. Mathew said. "Ultimately, nature has its own way of curing."

Recent News

Techstars Demo Day.
  • On Campus
|Dec 1, 2022

Techstars Demo Day brings innovation to the historic stockyards

For the last 13 weeks, the founders of 10 of the world’s most innovative startups have been in Fort Worth perfecting their new physical health technology. They are part of the world’s first physical health accelerator, and now they are ready to show the fruits of their labor. Techstars Demo D...
Dr. Sid O'bryant Award
  • Our People
|Dec 1, 2022

HSC named the winner of the D Magazines 2022 Achievement in Medical Research Award

The extensive research done by Dr. Sid O’Bryant and his team at the Institute of Translational Research has earned the University of North Texas Health Science Center at Fort Worth the 2022 Medical Research Award by D Magazine. Dr. O’Bryant, the executive director of the ITR and a professor at t...
Dr. John Licciardone
  • Our People
|Nov 30, 2022

Key study results from HSC’s PRECISION Pain Research Registry published in JAMA Network Open

The Journal of the American Medical Association – Network Open has published findings from a recent HSC study about chronic lower back pain, race and the patient-physician relationship. The study revealed that Black patients reported worse outcomes for low back pain intensity and back-related d...
Ram flyer
  • Community
|Nov 23, 2022

Free pop-up medical, vision and dental clinic is just a week away

  The University of North Texas Health Science Center at Fort Worth and Remote Area Medical – RAM® — a nonprofit provider of pop-up clinics that delivers free quality dental, vision and medical care to those in need — are bringing the free health care clinic to Dallas on Dec. 3 and 4....